The Gene Editing Juggernaut is Picking Up Speed.

IF 0.3 4区医学 Q4 ENGINEERING, BIOMEDICAL

IEEE Pulse Pub Date : 2023-09-01 DOI:10.1109/MPULS.2023.3344054

Jim Banks

引用次数: 0

Abstract

CRISPR-Cas9, the tool for editing genes by precisely cutting DNA and letting the body's natural DNA repair processes take over, deservedly led to Nobel prizes in 2020 for its pioneers, Emmanuelle Charpentier and Jennifer Doudna. Since their breakthroughs in 2012, the technology has moved forward in leaps and bounds, and techniques to manipulate genes that were once the realm of science fiction are becoming very much science "fact."

查看原文本刊更多论文

基因编辑巨轮正在加速前进。

CRISPR-Cas9 是一种通过精确切割 DNA 并让人体的自然 DNA 修复过程接管来编辑基因的工具，它的先驱埃马纽埃尔-夏彭蒂耶和詹妮弗-杜德娜在 2020 年当之无愧地获得了诺贝尔奖。自从他们在 2012 年取得突破以来，这项技术取得了突飞猛进的发展，曾经只属于科幻小说领域的基因操作技术正逐渐成为科学 "事实"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

IEEE Pulse ENGINEERING, BIOMEDICAL-

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.

文献相关原料

公司名称	产品信息	采购帮参考价格